Dyne Therapeutics, Inc. SEC filings DYN
Dyne Therapeutics, Inc. has 796 filings in SEC EDGAR's recent list, going back to Jul 23, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 22, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2025 | Dec 9, 2025 |
| 8-K |
Current report
New debt
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 30, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | May 30, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 3, 2024 | Aug 31, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 22, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 22, 2024 | May 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 20, 2024 | May 20, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 25, 2023 | May 24, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Other events
|
Sep 12, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 5, 2022 | Jul 5, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 3, 2022 |
| 8-K |
Current report
Results of operations
|
May 2, 2022 | May 2, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Other events
|
Dec 3, 2021 | Dec 2, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2021 | May 27, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2021 | May 26, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2021 | Mar 4, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 19, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 9, 2020 | Dec 4, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 21, 2020 | Sep 21, 2020 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DYN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1818794
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.